Precision BioSciences (DTIL) Misses Q2 EPS by 50c

Precision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($1.26), $0.50 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Fox reports Q4 earnings beat on World Cup ad revenue boost, shares gain
• Ralph Lauren (RL) Tops Q1 EPS by 35c; offers revenue
• Installed Building Products (IBP) Tops Q2 EPS by 36c